440 results
PCRonline @ ESC Congress 2021: the interventional cardiology perspective!
21 Jul 2021
Make sure you stay up to date with what's new and hot in interventional cardiology at this year's #ESCCongress!
EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries:
- Left atrial appendage occlusion with the WATCHMAN FLX: The Alster-FLX Registry
- Anatomical snuffbox for coronary angiography and interventions
- Randomized comparison between Radial and Femoral Large-bore access Complex PCI
- Experience with BRS for treatment of de novo native peripheral artery lesions
- Clinical validation of...
EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in imaging:
- A randomized study comparing imaging guided implantation of Orsiro and Xience: the CASTLE study
- Impact of different optimal stent implantation definitions in OCT-guide PCI
- Risk-stratification in ACS by comprehensive morphofunctional assessment with OCT
- 7.5 years follow-up after OCT-guided PCI: report...
EuroPCR 2021 Hotlines / Late-Breaking Trials: CENTURY JSV, SORT OUT IX, OUTDES, Epic02-RANGO, PIONEER III, and more!
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in stents:
- First machine learning derived risk score for target lesion failure
- Ultrathin versus Conventional Second-Generation DES: Meta-Analysis of RCTs
- Five-year outcomes after coronary stenting of small vessels - CENTURY JSV study
- 2-year outcomes of the randomized SORT OUT IX Trial
- Outcomes of...
Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction - FLOWER-MI
26 May 2021
This investigator-initiated randomised, open-label, multicentre trial compares FFR versus angiography guided strategies for treating non-culprit lesions in patients presenting with STEMI and multivessel coronary artery disease. The results of this study were released during ACC.21.
Reviewer
Reviewer
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in BRS/BVS:
- Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
- France Absorb registry: final five years follow-up
- A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
- Three-year follow-up of the prospective bvs stemi strategy-it study
- Final five-year results of AIDA trial
- Bioresorbable...
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in drugs & devices:
- POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
- CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
- PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
Paclitaxel and sirolimus coated balloons: create evidence before claims
20 May 2021 – From EuroPCR 2021
Watch this session presented by Mohd Ali Rosli, Bruno Scheller, Raban Jeger and Sylvia Otto in order to join a controversial discussion about a sirolimus and paclitaxel coated balloon approach, to follow a dedicated discussion on existing evidence on efficacy and safety for paclitaxel and sirolimus coated balloons...
Empowering DES performance in complex patients to maximise efficacy and safety outcomes
20 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...
Latest insights: when to choose orbital atherectomy
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Surendra Avula and Ajay Kirtane in order to understand the challenges of treating severe calcium, to know about the OAS overview with dual-action MOA technology and the clinical evidence supporting its use, and to be introduced to treatment technique.
